Syschem (India) Ltd.

View in App
60.99 +0.14 ▲0.2%

03 May 2024, 04:00:00 PM
Volume: 20,518

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.syschem.in
Market Cap 242.57 Cr.
Enterprise Value(EV) 243.75 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.86 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 71.07 Trailing Twelve Months Ending 2023-12
Industry PE 42.14 Trailing Twelve Months Ending 2023-12
Book Value / Share 14.35 Trailing Twelve Months Ending 2023-12
Price to Book Value 4.24 Calculated using Price: 60.85
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 3.99 Cr. 39,863,000 Shares
FaceValue 10
About Syschem (India) Ltd.
Syschem India was incorporated on December 31, 1993 as Anil Pesticides and obtained certificate of commencement of business on February 1, 1994. The company is promoted by Anil Nibber, Atul Nibber and Ajay Kumar Singla.

Syschem (India) Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Syschem (India) Ltd. Performance

View details >>
1 Day
+0.23%
1 Week
-0.89%
1 Month
-6.26%
3 Month
-3.66%
6 Month
+14.64%
1 Year
+54.76%
2 Year
+389.88%
5 Year
+653.89%
10 Year
+709.96%

Syschem (India) Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -32.44 -25.21 -19.78 4.43 7.67 -17.24 -66.17 -26.16 31.84
Return on Capital Employed (%) -10.6 -8.3 -6.68 2.68 5.51 -8.22 -29.75 -12.18 38
Return on Assets (%) -7.41 -4.69 -3.41 0.69 1.3 -3.06 -8.28 -2.64 6.17

Syschem (India) Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 11 9 7 9 12 10 7 7 22 25
Non Curr. Liab. 20 19 13 12 11 12 26 23 25 30
Curr. Liab. 19 18 22 34 37 39 41 26 43 29
Minority Int.
Equity & Liab. 50 45 42 56 61 61 74 56 90 84
Non Curr. Assets 35 33 31 30 28 30 32 32 32 34
Curr. Assets 15 13 11 26 32 31 42 24 59 50
Misc. Exp. not W/O
Total Assets 50 45 42 56 61 61 74 56 90 84

Syschem (India) Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 11 4 13 67 93 77 68 59 114 202
Other Income 0 0 0 0 0 0 0 0
Total Income 11 4 13 67 93 77 69 59 114 202
Total Expenditure -14 -5 -13 -63 -90 -77 -74 -58 -105 -195
PBIDT -3 -1 0 3 4 0 -5 1 9 8
Interest -1 0 0 0 0 0 0 0 0 0
Depreciation -2 -2 -2 -2 -2 -2 -2 -3 -3 -3
Taxation 1 1 1 0 -1 0 2 0 -2 -2
Exceptional Items 0
PAT -4 -2 -1 0 1 -2 -6 -2 5 3
Adjusted EPS -2 -1 -1 0 0 -1 -2 -1 1 1

Syschem (India) Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 4 1 0 6 0 -2 3 4 1 -8
Cash Fr. Inv. -3 0 0 0 0 2 -4 -4 -1 9
Cash Fr. Finan. -1 -2 -1 -7 0 0 0 0 0 0
Net Change 0 -1 0 0 0 0 0 0 1
Cash & Cash Eqvt 1 0 0 0 0 0 0 0 0 1

Syschem (India) Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 16.34 21.78 52.10 53.82 53.82 53.82 53.79 53.89 53.89
Public 83.66 78.22 47.90 46.18 46.18 46.18 46.21 46.11 46.11
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Syschem (India) Ltd. Announcements

View details >>
Sat, 27 Apr 2024
Board Meeting Intimation for Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) 2015 The Intimation For The Board Meeting Dated 6Th Of May 2024
SYSCHEM (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2024 inter alia to consider and approve As per regulation 29 per SEBI (Listing Obligations and Disclosure requirements) 2015: the Intimation of the Board meeting dated 6th of May 2024.
Thu, 25 Apr 2024
Compliance: Regulation 40(10) For The Year Ended 31 St March 2024
Compliance as per regulation 40(10) of LODR 2015 for the year ended 31st March 2024.
Thu, 18 Apr 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliance: As per regulation 39(3) and 30 of SEBI(Listing Obligations and Disclosure requirement) 2015 the board approval for issuance of duplicate share certificates.

Syschem (India) Ltd. Technical Scans

View details >>
Fri, 03 May 2024
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 1 Year High Increase in 1 Year

Syschem (India) Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 361,915.69 1,508.40 -0.7%
Cipla Ltd. 115,033.60 1,424.40 +0.3%
Dr. Reddy's Laboratories Ltd. 105,928.76 6,332.85 +0.7%
Divi's Laboratories Ltd. 104,873.36 3,937.05 -0.7%
Zydus Lifesciences Ltd. 100,321.53 992.00 +0.4%
Mankind Pharma Ltd. 92,708.18 2,305.15 -1.2%
Torrent Pharmaceuticals Ltd. 92,483.60 2,732.60 +2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.64 1,508.40 -0.7%
Cipla Ltd. Consolidated 2023-12 31.02 1,424.40 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.26 6,332.85 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-12 75.83 3,937.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 33.74 992.00 +0.4%
Mankind Pharma Ltd. Consolidated 2023-12 53.68 2,305.15 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 61.90 2,732.60 +2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.80 1,508.40 -0.7%
Cipla Ltd. Consolidated 2023-12 4.44 1,424.40 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.94 6,332.85 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-12 8.05 3,937.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.32 992.00 +0.4%
Mankind Pharma Ltd. Consolidated 2023-12 10.44 2,305.15 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.93 2,732.60 +2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,508.40 -0.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,424.40 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,332.85 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,937.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 992.00 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,305.15 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,732.60 +2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,508.40 -0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,424.40 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,332.85 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,937.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 992.00 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,305.15 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,732.60 +2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,508.40 -0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,424.40 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,332.85 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,937.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 992.00 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,305.15 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,732.60 +2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,508.40 -0.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,424.40 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,332.85 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,937.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 992.00 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,305.15 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,732.60 +2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,508.40 -0.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,424.40 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,332.85 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,937.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 992.00 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,305.15 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,732.60 +2.2%

Syschem (India) Ltd. FAQ's

What is Syschem (India) share price?
Can I buy Syschem (India) shares now?
What is the Market Cap of Syschem (India)?
What are the key metrics to analyse Syschem (India)?
What is the 52 Week High and Low of Syschem (India)?
What is the trend of Syschem (India) share price?